Zivo Bioscience Inc (ZIVO) — Strategic Asset Allocation Index

Latest as of September 2022: 13.8%

Zivo Bioscience Inc (ZIVO) has a Strategic Asset Allocation Index of 13.8% as of September 2022. Strategic assets (PP&E of $210.76K plus long-term investments of $-) total $210.76K, measured against net assets of $1.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

13.8%
Strategic Assets / Net Assets

Strategic Assets

$210.76K
PP&E + LT Investments

PP&E

$210.76K
USD

Net Assets

$1.52 Million
USD

Zivo Bioscience Inc Strategic Asset Allocation Index (2021–2021)

This chart shows how Zivo Bioscience Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the index stands at 13.8%, representing strategic assets of $210.76K against net assets of $1.52 Million USD. Explore how efficiently does Zivo Bioscience Inc generate cash to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Zivo Bioscience Inc (2021–2021)

The table below presents the year-by-year Strategic Asset Allocation Index for Zivo Bioscience Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Zivo Bioscience Inc (ZIVO) market capitalisation.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2021 0.5% $27.23K $27.23K $- $6.04 Million
pp = percentage points